Control of normal cell differentiation and the phenotypic reversion of malignancy in myeloid leukaemia.
about
Cloning of a gene (RIG-G) associated with retinoic acid-induced differentiation of acute promyelocytic leukemia cells and representing a new member of a family of interferon-stimulated genesThe "virgin birth", polyploidy, and the origin of cancerDown regulation of specific binding of [20-3H]phorbol 12,13-dibutyrate and phorbol ester-induced differentiation of human promyelocytic leukemia cells.Differentiation therapy of leukemia: 3 decades of development.All-trans retinoic acid and hematopoietic growth factors regulating the growth and differentiation of blast progenitors in acute promyelocytic leukemia.Specific binding of murine leukemia inhibitory factor to normal and leukemic monocytic cells.Induction of erythroid differentiation and modulation of gene expression by tiazofurin in K-562 leukemia cells.Purification and characterization of human granulocyte colony-stimulating factor (G-CSF).Regulation of cell surface receptors for different hematopoietic growth factors on myeloid leukemic cellsA novel regulatory myosin light chain gene distinguishes pre-B cell subsets and is IL-7 inducible.Enucleation of differentiated murine erythroleukemia cells in culture.Regulation of normal differentiation in mouse and human myeloid leukemic cells by phorbol esters and the mechanism of tumor promotionmda-7 (IL-24) Mediates selective apoptosis in human melanoma cells by inducing the coordinated overexpression of the GADD family of genes by means of p38 MAPK.Differential display as an approach to study differentiation and differentiation therapy in AML.Polar/apolar chemical inducers of differentiation of transformed cells: strategies to improve therapeutic potentialCannabinoids induce incomplete maturation of cultured human leukemia cellsDimethyl sulfoxide-inducible cytoplasmic factor involved in erythroid differentiation in mouse erythroleukemia (Friend) cells.Biological features of primary APL blasts: their relevance to the understanding of granulopoiesis, leukemogenesis and patient management.Induction of HL-60 differentiation by starvation for a single essential amino acid but not by protein synthesis inhibitors.Chapter One---Cancer terminator viruses and approaches for enhancing therapeutic outcomes.ERK5 pathway regulates transcription factors important for monocytic differentiation of human myeloid leukemia cells.Constitutive gene expression in myeloid leukemia and cell competence for induction of differentiation by the steroid dexamethasone.Identification of a population of bipotent stem cells in the HL60 human promyelocytic leukemia cell line.Alterations in polyamine levels induced by phorbol diesters and other agents that promote differentiation in human promyelocytic leukemia cells.mda-7/IL-24: multifunctional cancer-specific apoptosis-inducing cytokineRetinoids. Structure-function relationship in normal and leukemic hematopoiesis in vitroNull results in clinical trials: the need for a decision-theory approach.Functional changes in human leukemic cell line HL-60. A model for myeloid differentiation.Induction of plasmacytoid differentiation by phorbol ester in B-cell lymphoma cell lines bearing 8;14 translocations.Hydroxyl radical scavengers inhibit lymphocyte mitogenesisMechanisms that uncouple growth and differentiation in myeloid leukemia cells: restoration of requirement for normal growth-inducing protein without restoring induction of differentiation-inducing protein.Differentiation of human T-lymphoid leukemia cells into cells that have a suppressor phenotype is induced by phorbol 12-myristate 13-acetateNormal functional characteristics of cultured human promyelocytic leukemia cells (HL-60) after induction of differentiation by dimethylsulfoxideSecretion of plasminogen activator by bone marrow-derived mononuclear phagocytes and its enhancement by colony-stimulating factor.Induction of in vitro proliferation and maturation of human aneuploid myelogenous leukemic cellsEstablishment of the DU.528 human lymphohemopoietic stem cell lineInduction of differentiation of human and murine myeloid leukemia cells in culture by tunicamycin.Anti-K562 cell monoclonal antibodies recognize hematopoietic progenitors.Phorbol esters induce differentiation in human malignant T lymphoblasts.Tumor promoters enhance myeloid and erythroid colony formation by normal mouse hemopoietic cells.
P2860
Q24655577-B0DEDC58-E338-40E5-B33E-A44D9C2AFA03Q27024916-EFC2D2B1-E22A-463E-9169-C71BB05AE23BQ30450061-CE3FAB82-C1D6-49A2-A145-79B5AD8261EDQ33409795-764C9EDF-0BFE-4425-B87D-401B8149738EQ33604359-CB817D25-F62D-4088-82D9-A83237D94029Q33639878-12621548-992E-41AD-A1B0-9C991B59BC82Q33645437-EEDFAB7E-6042-4452-B7AE-871210B5B23BQ33879773-8585500B-458C-4E49-847E-BE0D7FE6CD02Q33880307-6D96F30A-03F8-4334-9E3A-E465ECA90B77Q33938133-6FDD1AF7-2C58-4294-BAB5-9ED1C7D08B44Q33988032-849C45F7-8CFA-4A8F-A49B-DF921AC64794Q34037444-40BF4838-1E9F-49EF-8275-1320477565BEQ34098956-237E2889-541B-454F-BA5C-941CCBEEEC02Q34116902-2BD9F8CB-3BE1-47AE-A17E-7305BC15326BQ34298232-37D89067-05D7-4937-93AD-98912D82B772Q34335183-05470297-3ED2-44F4-9846-754DAE3A5B94Q34346272-29AA92BB-222D-4861-8826-0D0F06A346BAQ34435497-7A317C30-386A-4DC2-A21C-CED1C66B1049Q34566144-2C8FD8CD-67B6-4D3B-A385-3E150B1D53E7Q35142325-E9180521-582C-4F54-8463-907A0C33A434Q35189239-15AAEC79-70BA-4CB1-8D59-6C4CF5F7F33AQ35307404-A17982A4-D5F3-48B2-868D-34A23A3172EEQ35387010-6E0AC3C4-6846-409F-A043-3B77BCE10BBDQ35423342-AF629ED2-251B-4CC1-B3C8-2A16364D2D45Q35609031-60125D4F-3057-4324-A01A-CE5FD5B599A4Q35808696-28318FB5-7BFE-4276-802F-4E8BAF240927Q36043832-FF0F3B27-7565-4EA6-8338-1641DCB65514Q36200880-2D27E43E-9675-4290-800C-EF187C8F3CA4Q36270502-1E977289-D41A-4DFC-A6E5-4CBD1D178435Q36282563-4A498909-4C03-4301-BB07-764A6BF1E4BDQ36304559-55C27E67-5334-48D7-895F-374A506F647CQ36323576-876A9EC7-5E81-4DA1-9CB7-9DDDEA7ABB7AQ36341387-CFD472DD-323B-4A4A-A565-621A903C5E4FQ36342713-894C938C-C304-4E94-8ACE-87A788F334A2Q36346480-F3F5D70D-CB07-419F-A0F3-2635A0921230Q36351205-FAF8246B-7189-47BC-BF3D-1BF72A03C57BQ36352329-071A605F-D322-4912-87A0-D0D74B0DAB13Q36379992-98B2394B-9A83-4FF4-9D22-29834257F528Q36390772-B98B7809-2A1C-49B8-9F54-F77F74B13DE5Q36398238-89E18534-AB64-499C-B3A9-37625DF1FA6F
P2860
Control of normal cell differentiation and the phenotypic reversion of malignancy in myeloid leukaemia.
description
1978 nî lūn-bûn
@nan
1978年の論文
@ja
1978年論文
@yue
1978年論文
@zh-hant
1978年論文
@zh-hk
1978年論文
@zh-mo
1978年論文
@zh-tw
1978年论文
@wuu
1978年论文
@zh
1978年论文
@zh-cn
name
Control of normal cell differe ...... lignancy in myeloid leukaemia.
@en
type
label
Control of normal cell differe ...... lignancy in myeloid leukaemia.
@en
prefLabel
Control of normal cell differe ...... lignancy in myeloid leukaemia.
@en
P2860
P356
P1433
P1476
Control of normal cell differe ...... lignancy in myeloid leukaemia.
@en
P2093
P2860
P2888
P304
P356
10.1038/274535A0
P407
P577
1978-08-01T00:00:00Z
P6179
1011707835